Probability of Success in BE studies [Design Issues]

posted by Achievwin – US, 2024-05-06 16:49 (43 d 01:07 ago) – Posting: # 23985
Views: 1,199

❝ Not sure whether I understand you correctly. POS is a Bayesian concept, where you need some prior information.


I am sorry I am equally confused in this example where do we find POS? what all I see is Sample size and anticipated power with certain N.

How come we have three different N with same assumptions?

❝ As usual, the T/R-ratio is the killer.


----- :-D:-D Thanks for reiterating my thought all along many of my colleagues are having issue in understanding T/R is main culprit than ISCV in Sample size estimates.

Please edcuate me on how to connect Power with POS?


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,057 posts in 4,840 threads, 1,641 registered users;
38 visitors (0 registered, 38 guests [including 8 identified bots]).
Forum time: 17:57 CEST (Europe/Vienna)

You should treat as many patients as possible with the new drugs
while they still have the power to heal.    Armand Trousseau

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5